SCHEMBL443741

SCHEMBL443741

[CH2]N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL359599 0.61 — —
Formaldehyde SCHEMBL15643109 0.61 — —
Formaldehyde SCHEMBL11234651 0.55 — —
SCHEMBL168279 0.55 — —
Formaldehyde SCHEMBL1460345 0.55 — —
SCHEMBL821396 0.55 — —
SCHEMBL639659 0.55 — —
SCHEMBL809291 0.55 — —
SCHEMBL390702 0.50 — —
SCHEMBL6724588 0.50 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108490187-A A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent 山东博科生物产业有限公司 2018-09-04 — — CN claimed
US-5302370-A Form complexes with rhenium and technetium INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1994-04-12 — — US claimed
CN-108471748-B Concentrated gibberellin solution formulations 瓦伦特生物科学有限责任公司 2021-04-23 — — CN disclosed
CN-108490187-A A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent 山东博科生物产业有限公司 2018-09-04 — — CN disclosed
CN-107106967-A Carbon capture solvents with alcohols and amines and methods of using such solvents 碳清洁解决方案有限公司 2017-08-29 — — CN disclosed
US-9186347-B1 Hydroxamates as therapeutic agents PHARMACYCLICS LLC (US) 2015-11-17 — — US disclosed
US-20150320718-A1 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS PHARMACYCLICS LLC 2015-11-12 — — US disclosed
CN-102391222-B As the hydroxamic acid ester of therapeutical agent PHARMACYCLICS INC. (US) 2015-10-21 — — CN disclosed
US-20140301976-A1 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS PHARMACYCLICS, INC. 2014-10-09 — — US disclosed
US-8779171-B2 Hydroxamates as therapeutic agents PHARMACYCLICS, INC. (US) 2014-07-15 — — US disclosed
CN-103459386-A N- (1,2, 5-oxadiazol-3-yl) pyridinecarboxamides and their use as herbicides BAYER IP GMBH 2013-12-18 — — CN disclosed
US-5571933-A Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 1996-11-05 — — US disclosed
US-5567831-A Non-steroidal sulfatase inhibitor compounds and their method of use DUGUESNE UNIVERSITY OF THE HOLY GHOST (US) 1996-10-22 — — US disclosed
US-5506345-A ANTIHYPOXIC AGENTS AMERSHAM INTERNATIONAL PLC (GB) 1996-04-09 — — US disclosed
EP-0663900-A1 METAL-OXIME CHELATES FOR USE AS RADIOPHARMACEUTICAL AGENTS AMERSHAM INTERNATIONAL plc (GB) 1995-07-26 — — EP disclosed
US-5387692-A A bisamine oxime compound containing a 2-nitroimidazole group AMERSHAM INTERNATIONAL PLC (GB) 1995-02-07 — — US disclosed
WO-1994008949-A2 METAL-OXIME CHELATES FOR USE AS RADIOPHARMACEUTICAL AGENTS AMERSHAM INTERNATIONAL PLC (GB) 1994-04-28 — — WO disclosed
US-5302370-A Form complexes with rhenium and technetium INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1994-04-12 — — US disclosed
US-4894466-A ANTICHOLESTEROL AGENTS MERCK & CO., INC. (US) 1990-01-16 — — US disclosed
EP-0331240-A2 Intermediates and processes for beta 6-hydroxymethyl HMG-COA MERCK & CO. INC. (US) 1989-09-06 — — EP disclosed
Send feedback